COHANCE

Cohance Lifesciences Limited

Pharmaceuticals

Share price

₹457

Market cap

₹17,487 Cr

1Y return

▼ 47%

A Hyderabad-based contract development and manufacturing organization serving leading global pharmaceutical and fine chemical companies. Cohance Life provides integrated services spanning process research and development through late-stage clinical and commercial manufacturing for new chemical entities. The company distinguishes itself through its commitment to delivering customized solutions that fulfill specific customer needs and expectations across the entire drug development lifecycle.

Investors holding Cohance Lifesciences Limited

ICICI Prudential Mutual Fund

Mutual Fund

4.19%

HDFC Mutual Fund

Mutual Fund

2.16%

SBI Life Insurance

Institution

1.75%

Recent moves 7

DSP Mutual FundDecreased

DSP Mutual Fund reduced its stake in Cohance Lifesciences from 4.29% to 3.53% by selling 28,99,996 shares in an open market transaction on August 7, 2026.

ICICI Prudential Mutual FundDecreased

ICICI Prudential Mutual Fund decreased its stake in Cohance Lifesciences from 4.49% to 4.19%, selling 11,44,549 shares worth ₹50.59 crore.

HDFC Mutual FundNew position

HDFC Mutual Fund entered Cohance Lifesciences with 82,49,905 shares, a 2.16% stake worth ₹364. 50 Cr at ₹441.90 apiece.

SBI Life InsuranceDecreased

SBI Life Insurance reduced its stake in Cohance Lifesciences from 2.02% to 1.75% by selling 10,25,469 shares worth ₹45.33 crore at ₹441.90 apiece.

SBI Mutual FundNew position

SBI Mutual Fund took a new position in Cohance Lifesciences, acquiring 1,27,34,835 shares worth ₹560.77 crore for a 3.33% stake. The share price was ₹441.90.

Invesco Mutual FundIncreased

Invesco Mutual Fund increased its stake in Cohance Lifesciences from 1.44% to 1.69%, buying 974,617 shares. The additional shares are worth ₹43.09 crore at a price of ₹441.90 apiece.

DSP Mutual FundNew position

DSP Mutual Fund bought 1,63,73,736 shares of Cohance Lifesciences Limited for ₹723.33 Cr at ₹441.90 apiece, establishing a new position of 4.28%.

Track the whales in Cohance Lifesciences Limited

Get alerted the moment a top investor buys or sells.